Company page

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation (ticker: ADPT) is a public company based in the United States, specializing in the field of biotechnology. With a market capitalization of approximately $2.42 billion, the company focuses on developing innovative solutions for diagnosing and treating diseases through its proprietary immune profiling technology. Adaptive Biotechnologies aims to advance personalized medicine by leveraging the immune system's potential to improve patient outcomes.